Kodiak Sciences grants CFO 66,500 stock options

Kodiak Sciences Inc. reported a compensation grant to Chief Financial Officer John A. Borgeson of stock options covering 66,500 shares of common stock on July 15, 2026.

Rhea-AI Filing Summary

Kodiak Sciences Inc. reported a compensation grant to Chief Financial Officer John A. Borgeson of stock options covering 66,500 shares of common stock on July 15, 2026. The options have an exercise price of $42.42 per share, expire on July 14, 2036, and were fully unvested at grant. One-forty-eighth of the shares vest one month after July 1, 2026, with the remaining shares vesting in forty-seven equal monthly installments thereafter, subject to his Continuous Service under the 2018 Equity Incentive Plan.

Insider Trade Summary

Grant/Award: 66,500 shares

Grant/Award 1 txn

Insider BORGESON JOHN A.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	66,500	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 66,500 contracts (Direct)

Footnotes (1)

1. F1. One-forty-eighth (1/48th) of the shares vest one month after July 1, 2026; the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 Equity Incentive Plan) as of each vesting date.

Key Figures

Stock options granted: 66,500 shares Exercise price: $42.42 per share Expiration date: July 14, 2036 +2 more

5 metrics

Stock options granted 66,500 shares Grant to CFO John A. Borgeson on July 15, 2026

Exercise price $42.42 per share Exercise price of stock option grant

Expiration date July 14, 2036 Option term end date for the grant

Underlying shares 66,500 shares Common stock underlying the reported options

Post-transaction derivative holdings 66,500 options Total derivative securities held after the reported acquisition

Key Terms

Stock Option (Right to Buy), Continuous Service, 2018 Equity Incentive Plan, vesting

4 terms

Stock Option (Right to Buy) financial

"Reported as "Stock Option (Right to Buy)" in the transaction details"

Continuous Service financial

"Subject to the Reporting Person's Continuous Service as of each vesting date"

2018 Equity Incentive Plan financial

"Continuous Service (as defined in the 2018 Equity Incentive Plan)"

vesting financial

"Shares vest in a series of forty-seven successive equal monthly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Kodiak Sciences (KOD) report for CFO John A. Borgeson?

Kodiak Sciences reported that CFO John A. Borgeson received a grant of 66,500 stock options on July 15, 2026. These options are compensation-based, carry a $42.42 exercise price, and relate to shares of Kodiak Sciences common stock, vesting over four years.

What is the exercise price of the new Kodiak Sciences (KOD) stock options granted to the CFO?

The stock options granted to Kodiak Sciences CFO John A. Borgeson have an exercise price of $42.42 per share. This means he can purchase Kodiak common shares at $42.42 once the options vest, subject to the grant’s vesting and service conditions.

How many Kodiak Sciences (KOD) shares underlie the stock options granted to the CFO?

The reported option grant covers 66,500 underlying shares of Kodiak Sciences common stock. All 66,500 shares were unvested at the time of grant and will become exercisable gradually according to the specified vesting schedule tied to Continuous Service.

What is the vesting schedule for Kodiak Sciences (KOD) CFO John A. Borgeson’s new options?

The options vest over 48 monthly installments: 1/48 vests one month after July 1, 2026, and the remaining shares vest in 47 equal monthly installments. Vesting requires the CFO’s Continuous Service under the 2018 Equity Incentive Plan.

When do Kodiak Sciences (KOD) CFO John A. Borgeson’s stock options expire?

The stock options granted to the Kodiak Sciences CFO expire on July 14, 2036. If unexercised by that date, they lapse. The grant is structured as a long-term incentive, subject to vesting and his ongoing Continuous Service with the company.

Were Kodiak Sciences (KOD) CFO John A. Borgeson’s options granted under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not affirmatively marked for this transaction. The reported grant is a compensation award under the 2018 Equity Incentive Plan rather than a sale or purchase under a trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/17/2026 - 04:40 PM Accepted by SEC EDGAR 07/17/2026 - 04:40 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BORGESON JOHN A.

(Last) (First) (Middle)

1250 PAGE MILL ROAD

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Kodiak Sciences Inc. [ KOD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$42.42	07/15/2026		A		66,500		(1)	07/14/2036	Common Stock	66,500	$0	66,500	D

Explanation of Responses:

1. One-forty-eighth (1/48th) of the shares vest one month after July 1, 2026; the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 Equity Incentive Plan) as of each vesting date.

	/s/ David Peinsipp, Attorney-in-Fact for John Borgeson	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)